![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
NEW WELLLINK
871634
VIBO
871245
REFORMER
833030
4
Hunan Sundy Science And Technology
300515
5
Qingdao Kutesmart Co.,Ltd.
300840
US Stock MarketDetailed Quotes
MNST Monster Beverage
- 55.690
- +0.340+0.61%
Close Mar 6 16:00 ET
- 55.690
- 0.0000.00%
Post 20:01 ET
54.20BMarket Cap37.38P/E (TTM)
55.750High54.810Low5.38MVolume55.120Open55.350Pre Close298.78MTurnover0.78%Turnover Ratio37.38P/E (Static)973.16MShares61.22552wk High9.10P/B38.49BFloat Cap43.32052wk Low--Dividend TTM691.14MShs Float61.225Historical High--Div YieldTTM1.70%Amplitude0.010Historical Low55.502Avg Price1Lot Size
Monster Beverage Stock Forum
Sign in to post a comment
$Monster Beverage (MNST.US)$ Is a 10% gain too much to ask? now that you lost 20% on Tesla, rebound with Monster
1
Third day result. Buy n sell. Keep green.
Always have a trading plan. Set clear goals. Define your risk tolerance and outline your entry and exit strategies before placing any trad
Always have a trading plan. Set clear goals. Define your risk tolerance and outline your entry and exit strategies before placing any trad
+1
2
$Monster Beverage (MNST.US)$ MNST to the Moon.
Earnings reports from $Disney (DIS.US)$ , $Airbnb (ABNB.US)$ , $Hilton Worldwide (HLT.US)$ , and energy drink giant $Monster Beverage (MNST.US)$ all warn that U.S. consumer spending is "definitely weakening." Due to rising prices and shrinking savings, Americans are cutting back on spending in areas such as dining and travel and becoming more cautious. Major U.S. cons...
2
Alrighty, folks, grab your bevvies and sit tight because Monster Beverage just pulled a massive faceplant in the stock market! I’m talking a 10% dive after hours on Wednesday.
So, here’s the deal: Monster thought they were the king of the energy drinks, but they only brought in $1.9 billion in Q2. Now, $1.9 billion sounds like a big ol' chunk of change, right? But the analysts—those cheeky buggers—were expecting $2.01 billio...
So, here’s the deal: Monster thought they were the king of the energy drinks, but they only brought in $1.9 billion in Q2. Now, $1.9 billion sounds like a big ol' chunk of change, right? But the analysts—those cheeky buggers—were expecting $2.01 billio...
2
Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
22
3
$Celsius Holdings (CELH.US)$ your rival $Monster Beverage (MNST.US)$ missed estimate, and you beat all estimates, please go back up to the price that you are supposed to be .
$Monster Beverage (MNST.US)$ further proof consumers aren't spending two and a half three bucks for a can of monster. if they can't afford McDonald's if they can't afford Burger King oh they missed two qsr parent company Papa Gino's missed the writing's on the wall plane is day.
consumers are not spending we are not consuming at the rate that we used to
consumers are not spending we are not consuming at the rate that we used to
2
1
Morning Movers
Gapping up
$Eli Lilly and Co (LLY.US)$ 's stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time.
$Apple (AAPL.US)$ 's stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...
Gapping up
$Eli Lilly and Co (LLY.US)$ 's stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time.
$Apple (AAPL.US)$ 's stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...
28
4
No comment yet
Trending Stocks
Discussing
As China's 'two sessions' commence: How will Chinese stocks perform?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
LostMoney850 OP : And resistance is Broken LFG!!!